Skip to main content
Premium Trial:

Request an Annual Quote

Lab901, Seegene Strike Distribution, Co-marketing Agreement

NEW YORK (GenomeWeb News) – The Korean PCR diagnostics company Seegene will distribute Lab901’s ScreenTape system in the Korean market, Lab901 said Monday.
 
Under the agreement, the two companies will co-market both the ScreenTape system and Seegene’s Seeplex products in the global market, the company said.
 
The Seeplex products are multiplex PCR-based tests designed to detect multiple pathogens, including sexually transmitted diseases, respiratory viruses, sepsis, human papillomavirus, and pneumonia.
 
Lab901’s ScreenTape system is an automated system for gel electrophoresis and is used in analysis of DNA, RNA, and protein samples. The Edinburgh, UK-based company said the DS12 ScreenTape system was designed specifically for the Seeplex tests, and automates the analysis of Seegene’s PCR pathogen tests.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.